Russell Investments Group Ltd. decreased its position in LivaNova PLC (NASDAQ:LIVN - Free Report) by 13.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 225,439 shares of the company's stock after selling 33,715 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.42% of LivaNova worth $11,825,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Arizona State Retirement System grew its holdings in LivaNova by 1.8% in the 3rd quarter. Arizona State Retirement System now owns 15,309 shares of the company's stock valued at $810,000 after buying an additional 264 shares during the last quarter. Headlands Technologies LLC grew its stake in shares of LivaNova by 33.3% in the fourth quarter. Headlands Technologies LLC now owns 1,807 shares of the company's stock worth $93,000 after acquiring an additional 451 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in LivaNova by 2.0% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,202 shares of the company's stock worth $1,438,000 after acquiring an additional 544 shares during the period. Kennedy Capital Management LLC increased its position in LivaNova by 0.3% during the third quarter. Kennedy Capital Management LLC now owns 301,078 shares of the company's stock worth $15,921,000 after acquiring an additional 888 shares during the period. Finally, Wedge Capital Management L L P NC raised its stake in LivaNova by 1.4% during the 4th quarter. Wedge Capital Management L L P NC now owns 73,845 shares of the company's stock valued at $3,821,000 after purchasing an additional 1,049 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.
LivaNova Price Performance
NASDAQ:LIVN traded up $1.23 during mid-day trading on Friday, hitting $64.15. The company's stock had a trading volume of 891,504 shares, compared to its average volume of 781,875. LivaNova PLC has a fifty-two week low of $42.75 and a fifty-two week high of $64.36. The company has a current ratio of 3.17, a quick ratio of 2.51 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $3.47 billion, a price-to-earnings ratio of -106.92 and a beta of 0.92. The stock has a fifty day moving average of $54.71 and a 200-day moving average of $51.06.
LivaNova (NASDAQ:LIVN - Get Free Report) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.28. LivaNova had a negative net margin of 2.68% and a positive return on equity of 13.59%. The firm had revenue of $294.90 million during the quarter, compared to analyst estimates of $278.17 million. During the same quarter in the prior year, the business posted $0.43 earnings per share. The company's quarterly revenue was up 12.0% compared to the same quarter last year. As a group, equities analysts forecast that LivaNova PLC will post 3.01 EPS for the current fiscal year.
Analyst Ratings Changes
Several research analysts have recently issued reports on the stock. StockNews.com upgraded shares of LivaNova from a "hold" rating to a "buy" rating in a report on Thursday, April 25th. Barclays upped their price objective on shares of LivaNova from $57.00 to $61.00 and gave the company an "equal weight" rating in a research report on Monday, February 26th. Robert W. Baird upped their price objective on shares of LivaNova from $58.00 to $66.00 and gave the company a "neutral" rating in a research report on Thursday. Needham & Company LLC reaffirmed a "buy" rating and set a $72.00 price objective on shares of LivaNova in a research report on Wednesday. Finally, Mizuho upped their price objective on shares of LivaNova from $75.00 to $80.00 and gave the company a "buy" rating in a research report on Thursday. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, LivaNova presently has an average rating of "Moderate Buy" and an average price target of $66.20.
Get Our Latest Stock Analysis on LivaNova
LivaNova Profile
(
Free Report)
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
See Also
Before you consider LivaNova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LivaNova wasn't on the list.
While LivaNova currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
